| KADIAN (20 MG) | 02184435 | Marketed | BGP Pharma ULC | May 2016 |
| KADIAN (50 MG) | 02184443 | Marketed | BGP Pharma ULC | May 2016 |
| KADIAN (100 MG) | 02184451 | Marketed | BGP Pharma ULC | Aug 2016 |
| KADIAN (10 MG) | 02242163 | Marketed | BGP Pharma ULC | May 2016 |
| KADIAN (200 MG) | 02559722 | Marketed | BGP Pharma ULC | Mar 2026 |
| M-EDIAT (5 MG) | 02320398 | Marketed | Ethypharm Inc | Jun 2025 |
| M-EDIAT (10 MG) | 02320428 | Marketed | Ethypharm Inc | Jun 2025 |
| M-EDIAT (20 MG) | 02320436 | Marketed | Ethypharm Inc | Jun 2025 |
| M-EDIAT (30 MG) | 02320444 | Marketed | Ethypharm Inc | Jun 2025 |
| M-ESLON (30 MG) | 02019949 | Marketed | Ethypharm Inc | Aug 2006 |
| M-ESLON (100 MG) | 02019965 | Marketed | Ethypharm Inc | Aug 2006 |
| M-ESLON (60 MG) | 02019957 | Marketed | Ethypharm Inc | Jul 2006 |
| M-ESLON (10 MG) | 02019930 | Marketed | Ethypharm Inc | Aug 2006 |
| M-ESLON (200 MG) | 02177757 | Marketed | Ethypharm Inc | Sep 2006 |
| M-ESLON (15 MG) | 02177749 | Marketed | Ethypharm Inc | Jul 2006 |
| MORPHINE HP 50 (50 MG) | 00617288 | Marketed | Sandoz Canada Inc. | Aug 2005 |
| MORPHINE LP EPIDURAL (0.5 MG) | 02021056 | Marketed | Sandoz Canada Inc. | Aug 2005 |
| MORPHINE LP EPIDURAL (1 MG) | 02021048 | Marketed | Sandoz Canada Inc. | Aug 2005 |
| MORPHINE SULFATE INJ 10MG/ML USP (10 MG) | 00392588 | Marketed | Sandoz Canada Inc. | Aug 2005 |
| MORPHINE SULFATE INJ 15MG/ML USP (15 MG) | 00392561 | Marketed | Sandoz Canada Inc. | Aug 2005 |
| MORPHINE SULFATE INJECTION (2 MG) | 02500701 | Marketed | JAMP Pharma Corporation | Apr 2021 |
| MORPHINE SULFATE INJECTION (10 MG) | 02500728 | Marketed | JAMP Pharma Corporation | Apr 2021 |
| MORPHINE SULFATE INJECTION (15 MG) | 02500736 | Marketed | JAMP Pharma Corporation | Apr 2021 |
| MORPHINE SULFATE INJECTION BP (10 MG) | 02474980 | Marketed | Sterimax Inc. | Sep 2018 |
| MORPHINE SULFATE INJECTION EPIDURAL (0.5 MG) | 02498278 | Marketed | Sterimax Inc. | May 2021 |
| MORPHINE SULFATE INJECTION EPIDURAL (1 MG) | 02498286 | Marketed | Sterimax Inc. | Jun 2021 |
| MORPHINE SULFATE INJECTION SDZ (10 MG) | 02382997 | Marketed | Sandoz Canada Inc. | Oct 2012 |
| MORPHINE SULFATE INJECTION USP (2 MG) | 02242484 | Marketed | Sandoz Canada Inc. | Aug 2005 |
| MORPHINE SULFATE INJECTION USP (100 MG) | 02491931 | Marketed | Sterinova Inc. | Aug 2020 |
| MORPHINE SULFATE INJECTION, USP (2 MG) | 02482681 | Marketed | Fresenius Kabi Canada Ltd | Dec 2019 |
| MORPHINE SULFATE INJECTION, USP (10 MG) | 02482746 | Marketed | Fresenius Kabi Canada Ltd | Dec 2019 |
| MS CONTIN (200 MG) | 02014327 | Marketed | Purdue Pharma | Dec 1993 |
| MS CONTIN (30 MG) | 02014297 | Marketed | Purdue Pharma | Dec 1993 |
| MS CONTIN (100 MG) | 02014319 | Marketed | Purdue Pharma | Dec 1993 |
| MS CONTIN (60 MG) | 02014300 | Marketed | Purdue Pharma | Dec 1993 |
| MS CONTIN (15 MG) | 02015439 | Marketed | Purdue Pharma | Dec 1993 |
| MS.IR (10 MG) | 02014211 | Marketed | Purdue Pharma | Dec 1993 |
| MS.IR (5 MG) | 02014203 | Marketed | Purdue Pharma | Dec 1991 |
| MS.IR (20 MG) | 02014238 | Marketed | Purdue Pharma | Dec 1991 |
| MS.IR (30 MG) | 02014254 | Marketed | Purdue Pharma | Dec 1991 |
| PMS-MORPHINE SULFATE (5 MG) | 02549794 | Marketed | Pharmascience Inc. | Jul 2024 |
| PMS-MORPHINE SULFATE (10 MG) | 02549808 | Marketed | Pharmascience Inc. | Jul 2024 |
| SANDOZ MORPHINE SR (15 MG) | 02244790 | Marketed | Sandoz Canada Inc. | Dec 2010 |
| SANDOZ MORPHINE SR (30 MG) | 02244791 | Marketed | Sandoz Canada Inc. | Dec 2010 |
| SANDOZ MORPHINE SR (60 MG) | 02244792 | Marketed | Sandoz Canada Inc. | Dec 2010 |
| SANDOZ MORPHINE SR (100 MG) | 02478889 | Marketed | Sandoz Canada Inc. | Dec 2018 |
| SANDOZ MORPHINE SR (200 MG) | 02478897 | Marketed | Sandoz Canada Inc. | Dec 2018 |
| STATEX (10 MG) | 00594644 | Marketed | Knight Therapeutics Inc. | Mar 2026 |
| STATEX (5 MG) | 00594652 | Marketed | Knight Therapeutics Inc. | Mar 2026 |
| TEVA-MORPHINE SR (15 MG) | 02302764 | Marketed | Teva Canada Limited | Jun 2011 |
| TEVA-MORPHINE SR (30 MG) | 02302772 | Marketed | Teva Canada Limited | Jun 2011 |
| TEVA-MORPHINE SR (60 MG) | 02302780 | Marketed | Teva Canada Limited | Jun 2011 |
| TEVA-MORPHINE SR (100 MG) | 02302799 | Marketed | Teva Canada Limited | Jun 2011 |
| TEVA-MORPHINE SR (200 MG) | 02302802 | Marketed | Teva Canada Limited | Jun 2011 |
| MORPHINE SULFATE INJECTION (10 MG) | 02561212 | Approved | Juno Pharma Canada Inc. | Sep 2025 |
| MORPHINE SULFATE INJECTION (15 MG) | 02561220 | Approved | Juno Pharma Canada Inc. | Sep 2025 |
| MORPHINE SULFATE INJECTION BP (15 MG) | 02474999 | Approved | Sterimax Inc. | Apr 2018 |
| MORPHINE SULFATE INJECTION USP (50 MG) | 02491885 | Approved | Sterinova Inc. | Aug 2019 |
| MORPHINE SULFATE INJECTION, USP (2 MG) | 02488620 | Approved | Fresenius Kabi Canada Ltd | May 2019 |
| MORPHINE SULFATE INJECTION, USP (4 MG) | 02488639 | Approved | Fresenius Kabi Canada Ltd | May 2019 |
| MORPHINE SULFATE INJECTION, USP (10 MG) | 02488647 | Approved | Fresenius Kabi Canada Ltd | May 2019 |
| PMS-MORPHINE SULFATE (25 MG) | 02549816 | Approved | Pharmascience Inc. | Jul 2024 |
| PMS-MORPHINE SULFATE (50 MG) | 02549824 | Approved | Pharmascience Inc. | Jul 2024 |
| PMS-MORPHINE SULFATE IR (30 MG) | 02549786 | Approved | Pharmascience Inc. | Jul 2024 |
| ZOMORPH (20 MG) | 02254182 | Approved | Ethypharm Inc | Jul 2005 |
| ZOMORPH (40 MG) | 02254190 | Approved | Ethypharm Inc | Jul 2005 |
| ZOMORPH (60 MG) | 02254204 | Approved | Ethypharm Inc | Jul 2005 |
| ZOMORPH (120 MG) | 02254212 | Approved | Ethypharm Inc | Jul 2005 |
| ZOMORPH (200 MG) | 02254220 | Approved | Ethypharm Inc | Jul 2005 |
| BAR-MORPHINE SR (15 MG) | 02453800 | Cancelled Pre Market | Bard Pharmaceuticals (1990) Inc | Apr 2024 |
| BAR-MORPHINE SR (30 MG) | 02453827 | Cancelled Pre Market | Bard Pharmaceuticals (1990) Inc | Apr 2024 |
| BAR-MORPHINE SR (60 MG) | 02453843 | Cancelled Pre Market | Bard Pharmaceuticals (1990) Inc | Apr 2024 |
| BAR-MORPHINE SR (100 MG) | 02453851 | Cancelled Pre Market | Bard Pharmaceuticals (1990) Inc | Apr 2024 |
| BAR-MORPHINE SR (200 MG) | 02453878 | Cancelled Pre Market | Bard Pharmaceuticals (1990) Inc | Apr 2024 |
| M.O.S. SULPHATE 10MG TAB (10 MG) | 02009765 | Cancelled Post Market | Valeant Canada Lp | Jul 2016 |
| M.O.S. SULPHATE 25MG TAB (25 MG) | 02009749 | Cancelled Post Market | Valeant Canada Lp | Jul 2016 |
| M.O.S. SULPHATE 50MG TAB (50 MG) | 02009706 | Cancelled Post Market | Valeant Canada Lp | Jul 2016 |
| M.O.S. SULPHATE 5MG TAB (5 MG) | 02009773 | Cancelled Post Market | Valeant Canada Lp | Jul 2016 |
| MORPHINE EXTRA-FORTE (50 MG) | 00869325 | Cancelled Post Market | Pfizer Canada Ulc | Jan 2020 |
| MORPHINE FORTE (25 MG) | 00869317 | Cancelled Post Market | Pfizer Canada Ulc | Mar 2019 |
| MORPHINE HP 25 - 25MG/ML (25 MG) | 00676411 | Cancelled Post Market | Sandoz Canada Inc. | Jul 2023 |
| MORPHINE SR (15 MG) | 02350815 | Cancelled Post Market | Sanis Health Inc. | Dec 2020 |
| MORPHINE SR (30 MG) | 02350890 | Cancelled Post Market | Sanis Health Inc. | Mar 2021 |
| MORPHINE SR (60 MG) | 02350912 | Cancelled Post Market | Sanis Health Inc. | Jun 2021 |
| MORPHINE SR (100 MG) | 02350920 | Cancelled Post Market | Sanis Health Inc. | Aug 2014 |
| MORPHINE SR (200 MG) | 02350947 | Cancelled Post Market | Sanis Health Inc. | Aug 2014 |
| MORPHINE SULFATE INJ 1MG/ML USP (1 MG) | 01980696 | Cancelled Post Market | Sandoz Canada Inc. | Apr 2021 |
| MORPHINE SULFATE INJ 2MG/ML USP (2 MG) | 01964437 | Cancelled Post Market | Sandoz Canada Inc. | Apr 2021 |
| MORPHINE SULFATE INJ 5MG/ML USP (5 MG) | 01964429 | Cancelled Post Market | Sandoz Canada Inc. | Apr 2021 |
| MORPHINE SULFATE INJECTION SDZ (1 MG) | 02382970 | Cancelled Pre Market | Sandoz Canada Inc. | Aug 2017 |
| MORPHINE SULFATE INJECTION SDZ (2 MG) | 02382989 | Cancelled Pre Market | Sandoz Canada Inc. | Aug 2017 |
| MORPHINE SULFATE INJECTION SDZ (15 MG) | 02383004 | Cancelled Pre Market | Sandoz Canada Inc. | Aug 2017 |
| MORPHINE SULFATE INJECTION USP (1 MG) | 00636908 | Cancelled Post Market | Icu Medical Canada Inc | May 2020 |
| MORPHINE SULFATE INJECTION USP (5 MG) | 00649619 | Cancelled Post Market | Icu Medical Canada Inc | Oct 2019 |
| MORPHINE SULFATE INJECTION USP (2 MG) | 00850314 | Cancelled Pre Market | Pfizer Canada Ulc | Mar 2019 |
| MORPHINE SULFATE INJECTION USP (10 MG) | 00850322 | Cancelled Post Market | Pfizer Canada Ulc | Jan 2020 |
| MORPHINE SULFATE INJECTION USP (15 MG) | 00850330 | Cancelled Post Market | Pfizer Canada Ulc | Jan 2020 |
| MORPHINE SULFATE INJECTION, USP (4 MG) | 02482703 | Cancelled Pre Market | Fresenius Kabi Canada Ltd | Dec 2025 |
| MORPHINE SULFATE INJECTION, USP (5 MG) | 02482711 | Cancelled Pre Market | Fresenius Kabi Canada Ltd | Dec 2025 |
| MORPHINE SULFATE INJECTION, USP (8 MG) | 02482738 | Cancelled Pre Market | Fresenius Kabi Canada Ltd | Aug 2024 |
| MORPHINE SULPHATE INJ 1MG/ML BP (1 MG) | 00885509 | Cancelled Post Market | David Bull Laboratories (Canada) Inc. | Aug 1998 |
| MORPHINE SULPHATE INJECTION 1MG/ML (1 MG) | 02137232 | Cancelled Post Market | Hospira Healthcare Corporation | Jan 2020 |
| MORPHINE SULPHATE INJECTION 2MG/ML (2 MG) | 02137240 | Cancelled Post Market | Hospira Healthcare Corporation | Nov 2018 |
| MORPHINE SULPHATE INJECTION 50MG/ML (50 MG) | 02137267 | Cancelled Post Market | Hospira Healthcare Corporation | Nov 2018 |
| MORPHINE SULPHATE INJECTION B.P. 25MG/ML (25 MG) | 02022672 | Cancelled Post Market | David Bull Laboratories (Canada) Inc. | Aug 1997 |
| MORPHINE SULPHATE INJECTION B.P. 50MG/ML (50 MG) | 02022680 | Cancelled Post Market | David Bull Laboratories (Canada) Inc. | Aug 1998 |
| MORPHINE SULPHATE INJECTION BP 2MG/ML (2 MG) | 02003759 | Cancelled Post Market | David Bull Laboratories (Canada) Inc. | Aug 1998 |
| MORPHINE SULPHATE INJECTION, USP (25 MG) | 02010380 | Cancelled Post Market | International Medication Systems Ltd. | Aug 1997 |
| MORPHINE SULPHATE INJECTION, USP LIQ50MG/ML (50 MG) | 02009897 | Cancelled Post Market | International Medication Systems Ltd. | Aug 1997 |
| MORPHINE SULPHATE INJECTION,USP LIQ 1.1MG/ML (1.1 MG) | 02010364 | Cancelled Post Market | International Medication Systems Ltd. | Aug 1997 |
| MORPHINE-EPD (1 MG) | 01949055 | Cancelled Post Market | Pfizer Canada Ulc | Mar 2019 |
| MORPHINE-EPD (0.5 MG) | 01949047 | Cancelled Post Market | Pfizer Canada Ulc | Jan 2020 |
| MS CONTIN SUPPOSITORIES - 100MG (100 MG) | 02145952 | Cancelled Post Market | Purdue Pharma | Jul 2003 |
| MS CONTIN SUPPOSITORIES - 200MG (200 MG) | 02145960 | Cancelled Post Market | Purdue Pharma | Jul 2003 |
| MS CONTIN SUPPOSITORIES - 30MG (30 MG) | 02146827 | Cancelled Post Market | Purdue Pharma | Jul 2003 |
| MS CONTIN SUPPOSITORIES - 60MG (60 MG) | 02145944 | Cancelled Post Market | Purdue Pharma | Jul 2003 |
| MS CONTIN TABLETS (5 MG) | 02229420 | Cancelled Pre Market | Purdue Pharma | Jul 2017 |
| MS CONTIN XL CAPSULES (30 MG) | 02242827 | Cancelled Pre Market | Purdue Pharma | Jul 2017 |
| MS CONTIN XL CAPSULES (60 MG) | 02242828 | Cancelled Pre Market | Purdue Pharma | Jul 2017 |
| MS CONTIN XL CAPSULES (90 MG) | 02242829 | Cancelled Pre Market | Purdue Pharma | Jul 2017 |
| MS CONTIN XL CAPSULES (120 MG) | 02242830 | Cancelled Pre Market | Purdue Pharma | Jul 2017 |
| MS CONTIN XL CAPSULES (150 MG) | 02242831 | Cancelled Pre Market | Purdue Pharma | Jul 2017 |
| MS CONTIN XL CAPSULES (200 MG) | 02242832 | Cancelled Pre Market | Purdue Pharma | Jul 2017 |
| MS IR SUP 10MG (10 MG) | 02014246 | Cancelled Post Market | Purdue Pharma | Jul 2003 |
| MS IR SUP 20MG (20 MG) | 02014262 | Cancelled Post Market | Purdue Pharma | Jul 2003 |
| MS IR SUP 30MG (30 MG) | 02014173 | Cancelled Post Market | Purdue Pharma | Jul 2003 |
| NTP-MORPHINE SR (15 MG) | 02346362 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-MORPHINE SR (30 MG) | 02346370 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-MORPHINE SR (60 MG) | 02346389 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-MORPHINE SR (100 MG) | 02346397 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| NTP-MORPHINE SR (200 MG) | 02346400 | Cancelled Pre Market | Teva Canada Limited | Aug 2015 |
| ORAMORPH SR TABLETS 100MG (100 MG) | 01988743 | Cancelled Post Market | Roxane Labs, Division Of Boehringer Ingelheim | Jul 2001 |
| ORAMORPH SR TABLETS 30MG (30 MG) | 01988727 | Cancelled Post Market | Roxane Labs, Division Of Boehringer Ingelheim | Jul 2002 |
| ORAMORPH SR TABLETS 60MG (60 MG) | 01988735 | Cancelled Post Market | Roxane Labs, Division Of Boehringer Ingelheim | Jul 2002 |
| PMS-MORPHINE SULFATE IR (5 MG) | 02549743 | Cancelled Pre Market | Pharmascience Inc. | Jul 2026 |
| PMS-MORPHINE SULFATE IR (10 MG) | 02549751 | Cancelled Pre Market | Pharmascience Inc. | Jul 2026 |
| PMS-MORPHINE SULFATE IR (20 MG) | 02549778 | Cancelled Pre Market | Pharmascience Inc. | Jul 2026 |
| PMS-MORPHINE SULFATE SR 100 MG (100 MG) | 02245287 | Cancelled Post Market | Pharmascience Inc. | Nov 2012 |
| PMS-MORPHINE SULFATE SR 15 MG (15 MG) | 02245284 | Cancelled Post Market | Pharmascience Inc. | Nov 2012 |
| PMS-MORPHINE SULFATE SR 200 MG (200 MG) | 02245288 | Cancelled Post Market | Pharmascience Inc. | Nov 2012 |
| PMS-MORPHINE SULFATE SR 30 MG (30 MG) | 02245285 | Cancelled Post Market | Pharmascience Inc. | Nov 2012 |
| PMS-MORPHINE SULFATE SR 60 MG (60 MG) | 02245286 | Cancelled Post Market | Pharmascience Inc. | Nov 2012 |
| STATEX DPS 50MG/ML (50 MG) | 00705799 | Cancelled Post Market | Paladin Pharma Inc. | Dec 2018 |
| STATEX DROPS 20MG/ML (20 MG) | 00621935 | Cancelled Post Market | Paladin Pharma Inc. | Sep 2018 |
| STATEX SUPPOSITORIES 20MG (20 MG) | 00596965 | Cancelled Post Market | Paladin Pharma Inc. | Dec 2021 |
| STATEX SUPPOSITORIES 30MG (30 MG) | 00639389 | Cancelled Post Market | Paladin Pharma Inc. | Feb 2022 |
| STATEX SUPPOSITORIES 5MG (5 MG) | 00632228 | Cancelled Post Market | Paladin Pharma Inc. | Mar 2021 |
| STATEX SYRUP 10MG/ML (10 MG) | 00647217 | Cancelled Post Market | Paladin Pharma Inc. | Sep 2018 |
| STATEX SYRUP 1MG/ML (1 MG) | 00591467 | Cancelled Post Market | Paladin Pharma Inc. | May 2019 |
| STATEX SYRUP 5MG/ML (5 MG) | 00591475 | Cancelled Post Market | Paladin Pharma Inc. | Sep 2018 |
| STATEX TABLET 25MG (25 MG) | 00594636 | Cancelled Post Market | Paladin Pharma Inc. | Feb 2023 |
| STATEX TABLETS 50MG (50 MG) | 00675962 | Cancelled Post Market | Paladin Pharma Inc. | Feb 2023 |
| STATEX-SUPPOSITORIES 10MG (10 MG) | 00632201 | Cancelled Post Market | Paladin Pharma Inc. | Jan 2021 |